Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2023-06-15 00:00:00 ET · period of report 2023-06-13 · accession 0001593968-23-001011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-15 | 2023-06-13 | ALLO | SATO VICKI L | Dir | A - Grant | $0.00 | +59.6K | 101.1K | +144% | $0 |
| D | 2023-06-15 | 2023-06-13 | ALLO | SATO VICKI L | Dir | A - Grant | $0.00 | +23.2K | 23.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-13 | A | A | 59,649 | $0.00 | 101,100 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-06-13 | A | A | 23,224 | $0.00 | 23,224 | D | $5.70 · — to 2033-06-13 | 23,224 Common Stock | (F1) Vesting in 12 equal monthly installments |